88 FR 56 pgs. 17628-17629 - Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Type: NOTICEVolume: 88Number: 56Pages: 17628 - 17629
Pages: 17628, 17629Docket number: [Docket No. DEA-1163]
FR document: [FR Doc. 2023-05943 Filed 3-22-23; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1163]
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 22, 2023. Such persons may also file a written request for a hearing on the application on or before May 22, 2023.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal,
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on January 13, 2023, Sigma Aldrich Research Biochemical, Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Cathinone | 1235 | I |
Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
Methaqualone | 2565 | I |
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | 7118 | I |
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) | 7201 | I |
Lysergic acid diethylamide | 7315 | I |
Tetrahydrocannabinols | 7370 | I |
Mescaline | 7381 | I |
2,5-Dimethoxyamphetamine | 7396 | I |
3,4-Methylenedioxymethamphetamine | 7405 | I |
Alpha-methyltryptamine | 7432 | I |
Dimethyltryptamine | 7435 | I |
5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
N-Benzylpiperazine | 7493 | I |
2C-H 2-(2,5-Dimethoxyphenyl)ethanamine) | 7517 | I |
MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
Heroin | 9200 | I |
Normorphine | 9313 | I |
Norlevorphanol | 9634 | I |
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
Amphetamine | 1100 | II |
Methylphenidate | 1724 | II |
Nabilone | 7379 | II |
Phencyclidine | 7471 | II |
Cocaine | 9041 | II |
Codeine | 9050 | II |
Ecgonine | 9180 | II |
Levorphanol | 9220 | II |
Meperidine | 9230 | II |
Methadone | 9250 | II |
Morphine | 9300 | II |
Thebaine | 9333 | II |
Levo-alphacetylmethadol | 9648 | II |
Noroxymorphone | 9668 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Carfentanil | 9743 | II |
Tapentadol | 9780 | II |
Fentanyl | 9801 | II |
The company plans to manufacture the listed controlled substances as reference standards. No other activities for these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-05943 Filed 3-22-23; 8:45 am]
BILLING CODE P